Literature DB >> 22169887

Differential phosphorylation of serum proteins reflecting inflammatory changes in schizophrenia patients.

Julian A J Jaros, Daniel Martins-de-Souza, Hassan Rahmoune, Emanuel Schwarz, F Markus Leweke, Paul C Guest, Sabine Bahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22169887     DOI： 10.1007/s00406-011-0283-6

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN： 0940-1334            Impact factor:   5.270


× No keyword cloud information.
  9 in total

1.  Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients.

Authors:  P C Guest; L Wang; L W Harris; K Burling; Y Levin; A Ernst; M T Wayland; Y Umrania; M Herberth; D Koethe; J M van Beveren; M Rothermundt; G McAllister; F M Leweke; J Steiner; S Bahn
Journal:  Mol Psychiatry       Date:  2010-02       Impact factor: 15.992

Review 2.  The complement system in schizophrenia.

Authors:  Karine R Mayilyan; Daniel R Weinberger; Robert B Sim
Journal:  Drug News Perspect       Date:  2008-05

Review 3.  Protein phosphorylation and neuronal function.

Authors:  S I Walaas; P Greengard
Journal:  Pharmacol Rev       Date:  1991-09       Impact factor: 25.468

4.  The need for phosphoproteomic approaches in psychiatric research.

Authors:  Daniel Martins-de-Souza; Paul C Guest; Natacha Vanattou-Saifoudine; Hendrik Wesseling; Hassan Rahmoune; Sabine Bahn
Journal:  J Psychiatr Res       Date:  2011-05-26       Impact factor: 4.791

5.  The role of statistical power analysis in quantitative proteomics.

Authors:  Yishai Levin
Journal:  Proteomics       Date:  2011-05-18       Impact factor: 3.984

6.  Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

Authors:  Norbert Stefan; Anita M Hennige; Harald Staiger; Jürgen Machann; Fritz Schick; Stefan M Kröber; Fausto Machicao; Andreas Fritsche; Hans-Ulrich Häring
Journal:  Diabetes Care       Date:  2006-04       Impact factor: 19.112

7.  Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia.

Authors:  Emanuel Schwarz; Rauf Izmailov; Michael Spain; Anthony Barnes; James P Mapes; Paul C Guest; Hassan Rahmoune; Sandra Pietsch; F Markus Leweke; Matthias Rothermundt; Johann Steiner; Dagmar Koethe; Laura Kranaster; Patricia Ohrmann; Thomas Suslow; Yishai Levin; Bernhard Bogerts; Nico Jm van Beveren; George McAllister; Natalya Weber; David Niebuhr; David Cowan; Robert H Yolken; Sabine Bahn
Journal:  Biomark Insights       Date:  2010-05-12

8.  Global proteomic profiling reveals altered proteomic signature in schizophrenia serum.

Authors:  Y Levin; L Wang; E Schwarz; D Koethe; F M Leweke; S Bahn
Journal:  Mol Psychiatry       Date:  2009-06-23       Impact factor: 15.992

9.  Clozapine impairs insulin action by up-regulating Akt phosphorylation and Ped/Pea-15 protein abundance.

Authors:  Fabio Panariello; Giuseppe Perruolo; Angela Cassese; Ferdinando Giacco; Ginevra Botta; Alessia P M Barbagallo; Giovanni Muscettola; Francesco Beguinot; Pietro Formisano; Andrea de Bartolomeis
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384
  9 in total
  4 in total

1.  Biomarkers and neurobiology of schizophrenia.

Authors:  Peter Falkai; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-08       Impact factor: 5.270

2.  Ecto-protein kinases and phosphatases: an emerging field for translational medicine.

Authors:  Garif Yalak; Yigal H Ehrlich; Bjorn R Olsen
Journal:  J Transl Med       Date:  2014-06-12       Impact factor: 5.531

Review 3.  Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future.

Authors:  Ashley L Comes; Sergi Papiol; Thorsten Mueller; Philipp E Geyer; Matthias Mann; Thomas G Schulze
Journal:  Transl Psychiatry       Date:  2018-08-16       Impact factor: 6.222

4.  Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways.

Authors:  Daniela Rodrigues-Amorim; Tania Rivera-Baltanás; María Del Carmen Vallejo-Curto; Cynthia Rodriguez-Jamardo; Elena de Las Heras; Carolina Barreiro-Villar; María Blanco-Formoso; Patricia Fernández-Palleiro; María Álvarez-Ariza; Marta López; Alejandro García-Caballero; José Manuel Olivares; Carlos Spuch
Journal:  Front Psychiatry       Date:  2019-11-29       Impact factor: 4.157
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.